TBDMS strategy, satisfy the need for high-throughput RNA
synthesis. A variety of other 2′-hydroxyl protecting groups
have appeared in the literature.7-11 The TBDMS, ACE, TOM,
and most of the previously described 2′-protecting groups
all share the same requirements for a manual solution-phase
2′-deprotection. The need for manual 2′-deprotection is time
and labor intensive, particularly for large-scale synthesis, and
a potential source for material losses and ribonuclease
contamination.
Scheme 1. Synthesis of 2′/3′-Lv Monomers
In this report, we have re-evaluated 2′- (and 3′-) O-acyl
ribonucleosides, as possible synthons for RNA synthesis. At
the onset, we recognized that 2′-O-acyl protecting groups
(e.g., benzoyl) in RNA synthesis had been largely unsuc-
cessful due to ease of 2′-3′ migration9 and lack of specificity
and compatibility with other groups. In fact, for these reasons,
2′-O-acyl protecting groups have only very rarely been used
in oligoribonucleotide synthesis.9,10 The levulinyl (Lv) group
has been previously described by van Boom and others as a
“transient” 5′-protecting group for ribonucleosides.12 Ogilvie
was the first to utilize the Lv group for transient 3′-protection
in conjunction with the procedures their group developed
for block coupling of 3′,5′-oligoribonucleotides.13 The present
study builds upon Ogilvie’s work as we examine, for the
first time, the application of 2′- (and 3′-) O-Lv ribonucleo-
sides as direct synthons for RNA synthesis. As documented
in an earlier study with 2′/3′-O-(2-chlorobenzoyl) ribonucleo-
sides,10b we reasoned that O-phosphitylation of a mixture of
interconverting 2′-O- and 3′-O-Lv ribonucleoside isomers
would provide separable, regioisomerically stable, phos-
phoramidite monomers that would be suitable for RNA (and
2′,5′-RNA) synthesis.
[2.2.2]octane (DABCO) (Scheme 1). Because N-levulination
of guanine proceeded sluggishly (20%),13b the dimethyl
formamidine (dmf) group14 was used instead as it has been
found that it can be efficiently introduced (>95%) and
removed under the same conditions as the N-Lv and O-Lv
groups.15 Uridine was subjected to the same steps, except
that it did not require base protection (Scheme 1). At this
stage, we obtained, as expected, inseparable mixtures of 2′/
3′-O-Lv regioisomers in favor of the 2′-O-Lv isomers (ca.
2:1 ratio for U, C, and A; 3:1 for G, after column
The required adenosine and cytosine monomers 3b/c and
4b/c were synthesized by sequential N-levulination of the
exocyclic amines (87-99%),13b 5′-dimethoxytritylation (DMTr;
88-90%), and 2′/3′-O-levulination (70-78%) using 2-chlo-
romethyl-pyridinium iodide (CMPI) and 1,4-diazabicyclo-
1
chromatography as determined by H NMR). The mixture
of 3 + 4 was then carried on to the final phosphitylation
step to afford mixtures of 5a-d and 6a-d in 77-85% yields
(% 6a-d > % 5a-d). Separation of the 2′-O- and 3′-O-
phosphoramidite regioisomers was possible by flash silica
gel column chromatography yielding 5a (19%), 6a (42%),
5b (10%), 6b (7%), 5c (29%), 6c (35%), 5d (22%), and 6d
(35%) in isomerically pure forms. These isolated yields are
generally lower than those obtained with TBDMS nucleo-
sides, particularly for the adenosine derivatives, and reflect
the very similar (tlc) chromatographic properties of each 5/6
pair (∆Rf ∼ 0.1). Nevertheless, we consider these results and
those described below to be most encouraging. The identities
of 5a-d and 6a-d were confirmed with ESI-MS in
conjunction with 2D NMR (31P-1H) experiments (Support-
ing Information).
(6) Pitsch, S.; Weiss, P. A.; Wu, X.; Ackermann, D.; Honegger, T. HelV.
Chim. Acta 1999, 82, 1753-1761.
(7) (a) Umemoto, T.; Wada, T. Tetrahedron Lett. 2004, 45, 9529-9531.
(b) Karwowski, B.; Seio, K.; Sekine, M. Nucleosides Nucleotides 2005,
24, 1111-1114. (c) Ohgi, T.; Matsutomi, Y.; Ishiyama, K.; Kitagawa, H.;
Shiba, Y.; Yano, J. Org. Lett. 2005, 7, 3447-3480. (d) Semenyuk, A.;
Foldesi, A.; Johansson, T.; Estmer-Nilsson, C.; Blomgren, P.; Brannvall,
M.; Kirseborn, L. A.; Kwiatkowski, M. J. Am. Chem. Soc. 2006, 128,
12356-12357. (e) Zhou, C.; Honcharenko, D.; Chattopadhyaya, J. Org.
Biomol. Chem. 2007, 5, 333-343.
(8) (a) Hayes, J. A.; Brunden, M. J.; Gilham, P. T.; Gough, G. R.
Tetrahedron Lett. 1985, 26, 2407-2410. (b) Ohtsuka, E.; Tanaka, S.;
Ikehara, M. J. Am. Chem. Soc. 1978, 100, 8210-8213. (c) Schwartz, M.
E.; Breaker, R. R.; Asteriadis, G. T.; deBear, J. S.; Gough, G. R. Bioorg.
Med. Chem. Lett. 1992, 2, 1019-1024.
(9) Griffin, B. E.; Reese, C. B. Tetrahedron Lett. 1964, 2925-2931.
(10) (a) Kempe, T.; Chow, F.; Sundquist, W. I.; Nardi, T. J.; Paulson,
B.; Peterson, S. M. Nucleic Acids Res. 1982, 10, 6695-6714. (b) Rozners,
E.; Renhofa, R.; Petrova, R.; Popelis, J.; Kumpins, V.; Bizdena, E.
Nucleosides Nucleotides 1992, 11, 1579-1593. (c) Reese, C. B.; Trentham,
D. R. Tetrahedron Lett. 1965, 2467-2472.
(11) Parley, N.; Baraguey, C.; Vasseur, J. J.; Debart, F. Org. Lett. 2006,
8, 3869-3872.
(12) (a) van Boom, J. H.; Burgers, P. M. J. Tetrahedron Lett. 1976,
4875-4878. (b) Ohtsuka, E.; Iwari, S. Nucleic Acids Res. 1988, 16, 9443-
9456.
With phosphoramidite monomers in hand, a 3′,5′-linked
RNA sequence (8) was synthesized on a 1 µmol scale using
monomers 5a-d (0.15 M in MeCN), 0.25 M 5-ethylthiotet-
razole (ETT) as an activator, and 14 min coupling cycles
(Table 1).
(13) (a) Ogilvie, K. K.; Nemer, M. J. Can. J. Chem. 1980, 58, 1389-
1397. (b) Ogilvie, K. K.; Nemer, M. J.; Hakimelahi, G. H.; Proba, Z. A.;
Lucas, M. Tetrahedron Lett. 1982, 23, 2615-2618. (c) Nemer, M. Ph.D.
Thesis, McGill University, Montreal, 1982 (Supervisor: K.K. Ogilvie).
(14) McBride, L.; Kierzek, R.; Beaucage, S.; Caruthers, M. J. Am. Chem.
Soc. 1986, 108, 2040-2048.
(15) Saneyoshi, H.; Seio, K.; Sekine, M. J. Org. Chem. 2005, 70, 10453-
10460.
790
Org. Lett., Vol. 9, No. 5, 2007